117 related articles for article (PubMed ID: 34845164)
1. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway.
Wang H; Shan S; Wang H; Wang X
Anticancer Drugs; 2022 Jan; 33(1):e700-e710. PubMed ID: 34845164
[TBL] [Abstract][Full Text] [Related]
2. Circ_0085495 knockdown reduces adriamycin resistance in breast cancer through miR-873-5p/integrin β1 axis.
Xie H; Zheng R
Anticancer Drugs; 2022 Jan; 33(1):e166-e177. PubMed ID: 34387598
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of circATXN7 represses non-small cell lung cancer growth by releasing miR-7-5p.
Li D; Fu Z; Dong C; Song Y
Thorac Cancer; 2022 Jun; 13(11):1597-1610. PubMed ID: 35445786
[TBL] [Abstract][Full Text] [Related]
4. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
Wei S; Qi L; Wang L
Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
[TBL] [Abstract][Full Text] [Related]
6. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p/SALL4 axis.
Xia H; Niu Q; Ding Y; Zhang Z; Yuan J; Jin W
J Mol Histol; 2021 Aug; 52(4):729-740. PubMed ID: 34050851
[TBL] [Abstract][Full Text] [Related]
8. Circ_KIAA1199 inhibits MSI1 degradation by targeting miR-34c-5p to drive the malignant cell behaviors and tumor growth of colorectal cancer.
Zhang Y; Yu H; Guo Z
Anticancer Drugs; 2022 Jan; 33(1):e134-e144. PubMed ID: 34387591
[TBL] [Abstract][Full Text] [Related]
9. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis.
Wang Y; Lin Q; Song C; Ma R; Li X
Cell Cycle; 2020 Dec; 19(23):3289-3302. PubMed ID: 33131409
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA 0007255 regulates the progression of breast cancer through miR-335-5p/SIX2 axis.
Jia Q; Ye L; Xu S; Xiao H; Xu S; Shi Z; Li J; Chen Z
Thorac Cancer; 2020 Mar; 11(3):619-630. PubMed ID: 31962380
[TBL] [Abstract][Full Text] [Related]
11. Circ_0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer.
Xu S; Luo W; Li M; Li Q; Hong W; Gao Y; Yang J; Song H; Chen L; Yang Y; Yang C
Clin Breast Cancer; 2023 Jan; 23(1):71-83. PubMed ID: 36289041
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axis.
Xu Y; Ren Z; Wang X; Ren M
J Gene Med; 2022 May; 24(5):e3413. PubMed ID: 35106863
[TBL] [Abstract][Full Text] [Related]
14. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway.
Li X; He J; Ren X; Zhao H; Zhao H
Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276
[TBL] [Abstract][Full Text] [Related]
15. Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1.
Luo S; Deng F; Yao N; Zheng F
Anticancer Drugs; 2022 Jan; 33(1):e286-e298. PubMed ID: 34407050
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer.
Chang F; Li J; Sun Q; Wei S; Song Y
Bioengineered; 2022 Apr; 13(4):8806-8822. PubMed ID: 35287543
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
Wang J; Yang K; Cao J; Li L
Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis.
Zheng T; Chen W; Wang X; Cai W; Wu F; Lin C
Exp Eye Res; 2021 Oct; 211():108650. PubMed ID: 34102206
[TBL] [Abstract][Full Text] [Related]
19. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circ_0000592 elevates ANXA4 expression via sponging miR-1179 to facilitate tumor progression in gastric cancer.
Ji Z; Diao W; Shang J
Anticancer Drugs; 2022 Jan; 33(1):e644-e654. PubMed ID: 34459457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
